🔹 UGRO Capital: Receives RBI’s ‘No Objection’ for the amalgamation of its subsidiary Profectus Capital with itself.

🔹 Hindalco Industries: CFIUS review for its AluChem acquisition temporarily paused due to partial US government shutdown.

🔹 OneSource Specialty Pharma: Gets NSE and BSE ‘No Objection’ letters for the merger of four entities, including Steriscience Specialties and Brooks Steriscience.

🔹 BPCL: Incorporates a wholly owned subsidiary in Singapore — Bharat Petroleum Global Energy Services — to establish a crude oil and natural gas trading desk.

🔹 Brigade Enterprises: Partners with Primus Senior Living to develop three senior living communities in South India, with an estimated GDV of ₹750 crore.

🔹 Info Edge: Plans to invest up to ₹250 crore in the B8 Fund; its arm Smartweb will act as sponsor and investment manager.

🔹 MedPlus Health: One retail outlet in Andhra Pradesh receives a drug license suspension order.

🔹 GRM Overseas: Completes acquisition of Dubai-based GRM ARABIA FZCO.

🔹 IRFC: Board meeting scheduled on March 9 to consider FY27 borrowing plans; retail portion of OFS subscribed 1.55%.

🔹 Jain Resource: Promoter approaches SAT challenging a recent SEBI order.

🔹 Ramco Cements: Divests non-core assets worth ₹59.6 crore to Rainbow Foundations.

🔹 Indian Oil Corporation (IOCL): Board to meet on March 6 to consider a second interim dividend for FY26.

🔹 Jio Financial Services: Subscribes to 3.4 crore shares of subsidiary Jio Credit for ₹2,000 crore to support business operations.

🔹 MSTC: Emerges as L1 bidder for a Coal India tender to provide NRS Linkage auction services for three years.

🔹 Tata Steel: Acquires 262 crore shares in T Steel Holdings for ₹2,402 crore.

🔹 NBCC: Secures a ₹775 crore redevelopment order from Delhi Development Authority (DDA) for staff quarters.

🔹 JSW Energy: Receives NSE and BSE trading approval for 95.2 lakh shares allotted to promoter group entity JTPM Metal Traders.

🔹 Vishal Mega Mart: Promoter likely to offload 30.5 crore shares (6.5% stake) worth ₹3,508 crore via block deal at a floor price of ₹115 per share — a 10% discount to CMP; remaining stake subject to 150-day lock-in.

This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.

Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.